Comparing Symbicort vs Trelegy Ellipta
| Symbicort | Trelegy Ellipta |
|
|---|
| Symbicort (budesonide / formoterol) | Trelegy Ellipta (fluticasone / umeclidinium / vilanterol) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Symbicort is a combination inhaler that contains budesonide (a corticosteroid) and formoterol (a long-acting bronchodilator). Symbicort should only be used in people with moderate-to-severe asthma... View more |
Prescription only
Trelegy Ellipta is approved for both the once-daily treatment of adults with chronic obstructive pulmonary disease (COPD) or asthma. Trelegy Ellipta is an option for the treatment of asthma in... View more |
Related suggestions COPD
|
|||||||||||||||
| More about Symbicort (budesonide / formoterol) | More about Trelegy Ellipta (fluticasone / umeclidinium / vilanterol) | ||||||||||||||||
| Generic Status | |||||||||||||||||
|
No lower-cost generic available |
|||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Symbicort has an average rating of 6.5 out of 10 from a total of 216 ratings on Drugs.com. 53% of reviewers reported a positive effect, while 28% reported a negative effect. |
Trelegy Ellipta has an average rating of 6.0 out of 10 from a total of 163 ratings on Drugs.com. 46% of reviewers reported a positive effect, while 35% reported a negative effect. |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Side Effects | |||||||||||||||||
|
See also: Symbicort side effects in more detail. |
See also: Trelegy Ellipta side effects in more detail. |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Symbicort prices and generic prices |
View all Trelegy Ellipta prices |
||||||||||||||||
| Dosage Form(s) Available | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Other budesonide / formoterol brands include: Breyna |
N/A |
||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||||||||||
|
7.9 hours |
24 hours |
||||||||||||||||
| CSA Schedule ** View glossary of terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 765 drugs are known to interact with Symbicort:
|
A total of 508 drugs are known to interact with Trelegy Ellipta:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
July 21, 2006 |
September 18, 2017 |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | |||||||||||||||||
| More Information | |||||||||||||||||
| Patient resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.